News
Almost one third of life science companies set to...
New survey results from the Pistoia Alliance, the Quantum Economic Development Consortium (QED-C) and QuPharm show almost one third (31 percent) of life science organisations...
Clinical Trials
Byondis Investigational Antibody-Drug Conjugate SYD985 Selected for I-SPY 2...
Byondis B.V. announced that Quantum Leap Healthcare Collaborative selected the company’s investigational antibody-drug conjugate (ADC) SYD985 (trastuzumab duocarmazine) for a new investigational treatment arm in...
News
Tim Consult launches air cargo benchmarking initiative for pharma...
Air freight experts at Tim Consult have launched the special Market Intelligence Initiative “MII Pharma Air Cargo”, aimed at providing pharmaceutical industry specialists with a...
News
Arctoris contributes its capabilities and expertise to the fight...
Arctoris Ltd. supports global research efforts to find new therapeutics against COVID-19.
Scientists in academic centres and companies around the world desperately search for novel therapeutics...
Clinical Trials
Pfizer and BioNTech Granted FDA Fast Track Designation for...
Pfizer Inc. and BioNTech SE announced that two of the companies’ four investigational vaccine candidates from their BNT162 mRNA-based vaccine program (BNT162b1 and BNT162b2) being...
News
Idifarma appoints new head of site
IDIFARMA, a Spanish contract development and manufacturing organisation (CDMO) specialising in niche and highly potent products, has announced the appointment of Alfredo Gómez as its...
News
Coronavirus Vaccine: Cipla’s remdesivir Cipremi launched in India, lowest...
Pharma major Cipla said it has launched its generic version of antiviral drug remdesivir at a price which is among the lowest globally and is...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.